Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

InstaLipo™ Reduces Stubborn Fat Non-Surgically!

Posted on: 29 Jan 18

New York City, Jan. 29, 2018 (GLOBE NEWSWIRE) --

Are you struggling to lose those extra inches off your waist, hips, thighs, or buttocks? NYC plastic surgeon Dr. Sharon Giese is now offering InstaLipo™ – the latest non-surgical liposuction technique – to achieve up to 2 or more inches of fat reduction during your first treatment without the need for extensive recovery time!

The midsection and legs are among the most notorious problem areas for many patients trying to reduce unwanted fat and improve body contours. Even with consistent dieting and exercise, stubborn fat may remain around the waistline, hips, thighs, or buttocks. InstaLipo™ is clinically proven to shrink stubborn fat cells and tighten skin without any pain, surgery, or downtime!

InstaLipo™ is the only FDA approved non-surgical device for immediate size reduction,” says Dr. Giese. “During FDA approved clinical trials using InstaLipo™, patients lost an average of 3.5 inches after a single 32 minute session.”

The method? Red light therapy, which delivers photonic energy to the target area(s), draining fat cells of their contents (mainly fatty acids and triglycerides). These fat cells then shrink in size as your body naturally processes these contents, leading to a slimmer-looking lower body. Unlike traditional liposuction, which physically removes fat cells from your body, InstaLipo™ simply reduces the size of your fat cells, eliminating the risk of bruising or swelling associated with past fat removal methods. An additional benefit of InstaLipo™ treatment is the stimulation of collagen and elastin fibers beneath the surface of your skin, which can improve skin texture for a firmer, more youthful-looking appearance.

During InstaLipo™ treatment, patients simply lie down and relax while the InstaLipo™ device is positioned above each target area for periods of approximately 8 minutes. Low-level photonic energy is delivered to unwanted fat cells, effectively shrinking them. There are no incisions or stitches necessary with InstaLipo™ and patients can typically resume their daily activities immediately following treatment.

“Patients usually see substantial results with 1 treatment,” says Dr. Giese. “Additional treatments scheduled 1 week apart may be recommended to help you achieve your desired results.” Dr. Giese recommends a proper diet and consistent exercise plan following treatment to help patients maintain their InstaLipo™ results.

Dr. Sharon Giese is a board certified NYC plastic surgeon performing a variety of different facial rejuvenation, body sculpting, and non-surgical treatments. Dr. Giese attended Vassar College before earning her medical degree at Northwestern Medical School. She received plastic surgery training at Stanford University and completed a fellowship in breast and cosmetic surgery at Georgetown University. Dr. Giese is a proud member of the American Society of Plastic Surgeons, the American Board of Plastic Surgery, and the American Society of Aesthetic Plastic Surgeons. She has appeared on numerous media outlets, including Good Morning America, The Early Show, The Today Show, and The Dr. Oz Show to discuss the latest trends in cosmetic surgery.

If you are interested in learning more about InstaLipo™ , you can contact Dr. Sharon Giese at (212) 421-3400 or by requesting an appointment online to schedule your plastic surgery consultation.

CONTACT: For additional information: Dr. Sharon Giese 114 East 61st Street New York, New York 10065 (212) 421-3400

Last updated on: 30/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.